Regulatory challenges and considerations for the clinical application of CAR T cell therapy
Expert Opin Biol Ther
.
2021 May;21(5):549-552.
doi: 10.1080/14712598.2021.1887130.
Epub 2021 Feb 24.
Authors
Christina A Bachmeier
1
,
Tony J Kurian
1
,
Marco L Davila
1
Affiliation
1
Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
PMID:
33555927
DOI:
10.1080/14712598.2021.1887130
No abstract available
Publication types
Editorial
MeSH terms
Immunotherapy, Adoptive*
Receptors, Chimeric Antigen* / genetics
Substances
Receptors, Chimeric Antigen